LENALIDOMID Sandoz caps 15 mg 21 pce
7680674560203
CH-67456
L04AX04
07.16.4.
Reimbursement limitations:
LENALI.SA.09
LENALIDOMID SANDOZ en association avec l’ixazomib et la dexaméthasone
Après accord sur la prise en …
1 / 3
google
Details
- Product number
- 6745605
- CPT
- -
- Packaging group
- 21
- Unit
- Kapsel(n)
- Composition
- lenalidomidum 15 mg, cellulosum microcristallinum, lactosum 199.3 mg, carmellosum natricum conexum corresp. natrium 0.539 mg, magnesii stearas, gelatina, E 171, E 132, Drucktinte: lacca, E 172 (nigrum), propylenglycolum, kalii hydroxidum, pro capsula.
Articles (1)
Lenalidomid Sandoz 15 mg, Kapseln
Kapseln
21
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
15.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
199.3 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.539 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 867.75
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/02/2022
Authorization holder
Sandoz Pharmaceuticals AG
6343 Risch
Authorization information
- Swissmedic authorization number
- 67456
- Drug name
- Lenalidomid Sandoz, Kapseln
- Galenic form
- KAPS
- ATC Code
- L04AX04
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 05/05/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.4.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LENALIDOMID Sandoz caps 15 mg 21 pce
- Description (DE)
- LENALIDOMID Sandoz Kaps 15 mg 21 Stk
- Market launch
- 05/05/2020
- Narcotic (BTM)
- No